(2E)-1-(4-ethoxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 2g

Ethyl 2-(dibenzylamino)acetate, 95.0%, 100g

(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine, 95.0%, 250mg

(2S,4R)-4-(4-Bromobenzyl)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 2g

2,2-Dimethyl-3-[4-(trifluoromethyl)phenyl]propanoic acid, 100mg

3-Bromo-5-chloropyridine-4-carboxaldehyde, 95%, 1g

5-Methyl-1,2,3,4-tetrahydroquinoxaline, 500mg

2-Amino-4-methoxybenzoic Acid>97.0%(HPLC)(T)1g

(R)-2-Amino-2-(4-bromophenyl)acetic acid, 95+%, 250mg

Ethyl 4-amino-3-methoxybenzoate, 95.0%, 100g

2-Methyl-3-(piperidin-4-yloxy)pyridine, 100mg

N-(3-(Dimethylamino)propyl)tetradecanamide, 95.0%, 250mg

4-Bromo-2-methoxy-aniline, 97.0%, 1g